Status:

COMPLETED

The PATHFINDER Study: A Feasibility Trial

Lead Sponsor:

Beth Israel Deaconess Medical Center

Conditions:

Coronary Artery Disease

Delirium

Eligibility:

All Genders

60+ years

Phase:

EARLY_PHASE1

Brief Summary

The main purpose of this study is to determine whether a rational strategy of EEG guided multimodal general anesthesia using target specific sedative and analgesics could result in enhanced recovery a...

Detailed Description

The main purpose of this study is to determine whether a rational strategy of EEG guided multimodal general anesthesia using target specific sedative and analgesics could result in enhanced recovery a...

Eligibility Criteria

Inclusion

  • Age ≥ 60 years
  • Undergoing any of the following types of surgery with cardiopulmonary bypass limited to coronary artery bypass surgery (CABG), CABG+valve surgeries and isolated valve surgeries.

Exclusion

  • Preoperative left ventricular ejection fraction (LVEF) \<30%
  • Emergent surgery
  • Non-English speaking
  • Cognitive impairment as defined by total MoCA score \< 10
  • Currently enrolled in another interventional study that could impact the primary outcome, as determined by the PI
  • Significant visual impairment
  • Chronic opioid use for chronic pain conditions with tolerance (total dose of an opioid at or more than 30 mg morphine equivalent for more than one month within the past year)
  • Hypersensitivity to any of the study medications
  • Known history of alcohol (\> 2 drinks per day) or drug abuse Active (in the past year) history of alcohol abuse (≥5 drinks/day for men or ≥4 drinks/day for women) as determined by reviewing medical record and history given by the patient
  • Liver dysfunction (liver enzymes \> 4 times the baseline, all patients will have a baseline liver function test evaluation), history and examination suggestive of jaundice.

Key Trial Info

Start Date :

August 20 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 7 2020

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT04016740

Start Date

August 20 2019

End Date

July 7 2020

Last Update

January 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215